Ergebnis der Suchanfrage nach R&
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
- 3
Press Release - hubergroup at IndiaCorr Expo: HYDRO-i returns to where it all began
Ein Dokumentmehr Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
mehrStudy: Final Push for the Cyber Resilience Act — Nearly Two-Thirds of Companies Still Unaware
Study: Final Push for the Cyber Resilience Act — Nearly Two-Thirds of Companies Still Unaware The new EU cybersecurity directive brings multiple challenges for companies, including reporting obligations, the creation of Software Bills of Materials, and the shift to “secure by design” products. ONEKEY IoT & OT ...
mehrUCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...
mehrOttobock with strong H1 2025 results
mehr
Infineon strengthens startup ecosystem in India
mehrLAUDA DR. R. WOBSER GMBH & CO. KG
3LAUDA expands management responsibilities of Felix Heinrich-Bignasse and Enrico Bossart
mehrDrees & Sommer Designs Advanced Semiconductor R&D Facility for imec in Málaga
mehrTechnische Universität München
A new biotech hub for Munich
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE A new biotech hub for Munich Where science powers start-ups: Launching BioLabs|TUM • TUM Venture Labs cooperate with BioLabs and Lilly • 1,800 square meters of coworking lab space • Aiming at accelerating therapy development BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech start-ups ...
mehrYanfeng Unveils 2024 ESG Report: Driving Sustainability Forward
mehrNew Automated Cybersecurity Testing for Embedded Software Available in Compliance with RED II EN18031 Standard
New Automated Cybersecurity Testing for Embedded Software Available in Compliance with RED II EN18031 Standard With the new simplified, automated testing process, embedded software can be checked within minutes for potential vulnerabilities and non-compliance with the RED II, EN 18031-1 directive. Düsseldorf, 23 ...
mehr
LAUDA DR. R. WOBSER GMBH & CO. KG
2LAUDA earns silver medal from EcoVadis
mehrTherVacB: Advance Curative Strategy for Chronic Hepatitis B
mehrWorld Health Summit 2025: Registration Open - First High-Level Speakers Announced
Berlin (ots) - Registration for the World Health Summit 2025 is now open. From October 12-14, Berlin will once again host one of the most important strategic global health gatherings worldwide. Under the theme "Taking Responsibility for Health in a Fragmenting World", the summit brings together leading minds from academia, politics, the private sector, and civil ...
mehrXTEND Secures $30M Extension to Complete $70M Series B to Scale Its Battle-Proven Autonomous AI Robots Across America
Tampa, Fla. (ots/PRNewswire) - Aliya Capital Partners and Protego Ventures Co-Lead Strategic Series B Round alongside participating investors: Len Blavatnik's Claltech, Union-Tech Ventures & Chartered Group, as XTEND's AI Robotic Technology Proves Itself in Global Conflicts and the Company Opens Its New U.S. ...
mehrIchnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
New York and North Chicago, Ill. (ots/PRNewswire) - - ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today announced an ...
mehrLTS Lohmann Therapie-Systeme AG
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
Andernach / Montreal (ots) - LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality ...
mehr
Tata Elxsi and Infineon Partner to Accelerate EV Innovation in India
mehrLess than 30 days left to apply – don’t miss your chance
Ein DokumentmehrLAUDA DR. R. WOBSER GMBH & CO. KG
Norbert Hönninger celebrates 40 years with LAUDA
mehrLAUDA DR. R. WOBSER GMBH & CO. KG
4LAUDA Showcases AI Expertise in the SME Sector
mehr- 2
Höchst Industrial Park: Carbon capture pilot plant goes into operation
mehr - 3
Press Release - hubergroup opens India’s first production facility for Direct Food Contact inks
Ein Dokumentmehr
#1 Cyber Threat: Software Supply Chain Attacks Targeting Industry
#1 Cyber Threat: Software Supply Chain Attacks Targeting Industry The European Union Agency for Cybersecurity (ENISA) has identified software supply chain attacks as the top cyber threat – highlighting the urgent need to secure industrial IT and OT systems. The number of such incidents within the EU has more than doubled since 2020 Düsseldorf, 3 June 2025 – The German industrial sector is experiencing an increasing ...
mehrBIAL Announces Oral Presentation at GBA1 Meeting 2025
Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...
mehrInfosys Launches Over 200 Enterprise AI Agents, Part of Infosys Topaz™ AI Offerings and Google Cloud
Bengaluru, India (ots/PRNewswire) - Leveraging Google Cloud's agentic AI framework and Infosys Topaz, these agents are designed to transform enterprise processes Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced the launch of over 200 ...
mehrInfosys Launches Agentic AI Foundry, Part of Infosys Topaz™, to Accelerate Enterprise AI Journey
Bengaluru, India (ots/PRNewswire) - Tailored to develop and deploy enterprise AI agents at scale, the Foundry aims to transform businesses with reliable and responsible innovation Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced the ...
mehrForests’ role in addressing climate and biodiversity challenges
mehrEuropäischer Rechnungshof - European Court of Auditors
Działania UE na rzecz dodatkowych programów emerytalnych mających zagwarantować odpowiednią wysokość emerytur okazały się jak dotąd nieskuteczne
mehr